Status:
COMPLETED
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Atrial Fibrillation
Tachycardia, Ventricular
Eligibility:
All Genders
10-80 years
Phase:
PHASE4
Brief Summary
The study evaluates 3 different populations: It is an open, randomized, parallel-group study comparing the effectiveness of intravenous (iv) ajmaline with currently used antiarrhythmic drugs in the a...
Eligibility Criteria
Inclusion
- AF: Patients with isolated, idiopathic, sustained, symptomatic, recent onset(\>10 minutes to \<24 hours) atrial fibrillation.
- VT: Patients with ventricular tachycardia with good haemodynamic tolerability attending the emergency room or induced at the electrophysiology lab during testing for ventricular arrhythmias.
- Brugada Sd (BrS): First-degree relatives of a patient with Brugada Syndrome with a ECG non-diagnostic of the BrS.
Exclusion
- General: Pregnancy
- AF: Pre-existing heart disease.
- Secondary AF
- 2nd and 3rd degree AV block or RBBB associated with LAFB or LPFB (bifascicular block).
- LVF\<40%.
- Moderate-severe liver failure.
- AF with haemodynamic compromise.
- VT:VT with haemodynamic compromise.
- BrS:Pre-existing heart disease.
- 2nd and 3rd degree AV block or RBBB associated with LAFB or LPFB (bifascicular block).
- Moderate-severe liver failure.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT00702117
Start Date
June 1 2008
End Date
January 1 2010
Last Update
December 15 2010
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Servicio de Cardiología, Hospital Clínic
Barcelona, Barcelona, Spain, 08036
2
Hospital Donostia
Donostia / San Sebastian, Guipuzcoa, Spain
3
Hospital Puerta de Hierro
Madrid, Madrid, Spain
4
Hospital La Fe
Valencia, Valencia, Spain